This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)
Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.
>>>

CARA Insider Trading (Cara Therapeutics)

Insider Ownership Percentage: 6.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $943,215.14

Cara Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cara Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cara Therapeutics Share Price & Price History

Current Price: $8.39
Price Change: Price Decrease of -0.01 (-0.12%)
As of 05/16/2022 03:22 PM ET

This chart shows the closing price history over time for CARA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity

Cara Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2022Christopher PosnerCEOSell2,006$12.67$25,416.02201,031View SEC Filing Icon  
4/1/2022Frederique Ph.D. MenzaghiSVPSell1,784$11.91$21,247.44169,781View SEC Filing Icon  
4/1/2022Scott TerrillionInsiderSell1,642$11.91$19,556.2274,893View SEC Filing Icon  
3/3/2022Scott TerrillionInsiderSell1,787$11.38$20,336.06View SEC Filing Icon  
3/3/2022Thomas Charles ReillyCFOSell2,044$11.38$23,260.72View SEC Filing Icon  
2/25/2022Scott TerrillionInsiderSell1,972$10.29$20,291.88View SEC Filing Icon  
11/12/2021Jeffrey L. IvesDirectorSell8,180$16.04$131,207.20View SEC Filing Icon  
11/1/2021Joana GoncalvesInsiderSell1,000$17.15$17,150.00View SEC Filing Icon  
10/27/2021Joana GoncalvesInsiderSell1,000$15.00$15,000.00View SEC Filing Icon  
9/7/2021Derek T. ChalmersCEOSell20,000$15.47$309,400.00991,405View SEC Filing Icon  
8/30/2021Derek T ChalmersCEOSell8,440$14.20$119,848.001,011,405View SEC Filing Icon  
8/30/2021Frederique Ph.D. MenzaghiSVPSell3,847$14.20$54,627.40141,072View SEC Filing Icon  
8/30/2021Scott TerrillionInsiderSell1,759$14.20$24,977.8047,900View SEC Filing Icon  
8/30/2021Thomas Charles ReillyCFOSell1,982$14.20$28,144.40View SEC Filing Icon  
6/7/2021Martin VogelbaumDirectorSell8,640$13.05$112,752.0028,800View SEC Filing Icon  
4/21/2021Joana GoncalvesInsiderSell3,000$27.63$82,890.0043,610View SEC Filing Icon  
3/22/2021Joana GoncalvesInsiderSell3,000$19.65$58,950.0030,610View SEC Filing Icon  
3/5/2021Derek T ChalmersCEOSell3,103$17.98$55,791.94953,614View SEC Filing Icon  
3/5/2021Frederique Ph.D. MenzaghiSVPSell3,358$17.98$60,376.84122,677View SEC Filing Icon  
3/5/2021Scott TerrillionInsiderSell3,090$17.98$55,558.2054,432View SEC Filing Icon  
2/25/2021Derek T ChalmersCEOSell11,729$19.33$226,721.57955,343View SEC Filing Icon  
2/25/2021Frederique Ph.D. MenzaghiSVPSell5,003$19.33$96,707.99117,680View SEC Filing Icon  
2/25/2021Scott TerrillionInsiderSell4,004$19.33$77,397.3248,436View SEC Filing Icon  
1/21/2021Joana GoncalvesInsiderSell2,000$20.12$40,240.0028,075View SEC Filing Icon  
12/30/2020Derek T ChalmersCEOSell6,078$15.30$92,993.40936,593View SEC Filing Icon  
12/30/2020Frederique Ph.D. MenzaghiSVPSell2,812$15.30$43,023.60109,680View SEC Filing Icon  
12/30/2020Scott TerrillionInsiderSell1,946$15.30$29,773.8042,436View SEC Filing Icon  
12/28/2020Derek T ChalmersCEOSell5,000$16.00$80,000.00947,671View SEC Filing Icon  
12/21/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0027,373View SEC Filing Icon  
12/16/2020Derek T ChalmersCEOSell5,000$14.95$74,750.00928,921View SEC Filing Icon  
12/10/2020Derek T ChalmersCEOSell7,500$15.29$114,675.00933,921View SEC Filing Icon  
11/23/2020Joana GoncalvesInsiderSell2,000$15.31$30,620.0029,373View SEC Filing Icon  
11/19/2020Christopher PosnerDirectorSell2,000$15.82$31,640.0011,200View SEC Filing Icon  
11/17/2020Derek T ChalmersCEOSell11,799$16.00$188,784.00941,421View SEC Filing Icon  
11/17/2020Martin VogelbaumDirectorSell6,000$16.09$96,540.0014,400View SEC Filing Icon  
11/10/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0031,373View SEC Filing Icon  
10/20/2020Joana GoncalvesInsiderSell2,000$15.00$30,000.0033,373View SEC Filing Icon  
9/3/2020Derek T ChalmersCEOSell3,201$16.00$51,216.00953,220View SEC Filing Icon  
7/1/2020Derek T ChalmersCEOSell5,000$17.11$85,550.00961,421View SEC Filing Icon  
6/12/2020Joana GoncalvesInsiderSell10,627$15.05$159,936.3546,000View SEC Filing Icon  
6/3/2020Derek T ChalmersCEOSell4,300$16.01$68,843.00970,721View SEC Filing Icon  
6/1/2020Derek T ChalmersCEOSell700$16.00$11,200.00970,721View SEC Filing Icon  
6/1/2020Jeffrey L. IvesDirectorSell1,000$16.00$16,000.007,000View SEC Filing Icon  
5/22/2020Derek T ChalmersCEOSell371$16.00$5,936.00975,292View SEC Filing Icon  
5/20/2020Derek T ChalmersCEOSell1,200$16.00$19,200.00975,292View SEC Filing Icon  
5/12/2020Derek T ChalmersCEOSell4,929$16.00$78,864.00976,492View SEC Filing Icon  
5/12/2020Jeffrey L. IvesDirectorSell2,500$16.00$40,000.008,500View SEC Filing Icon  
4/21/2020Derek T ChalmersCEOSell6,348$15.56$98,774.88987,769View SEC Filing Icon  
4/21/2020Frederique Ph.D. MenzaghiSVPSell12,894$15.58$200,888.52117,386View SEC Filing Icon  
4/21/2020Jeffrey L. IvesDirectorSell2,500$16.00$40,000.008,500View SEC Filing Icon  
4/21/2020Scott TerrillionInsiderSell2,721$15.56$42,338.7641,103View SEC Filing Icon  
3/4/2020Jeffrey L. IvesDirectorSell2,500$16.00$40,000.008,500View SEC Filing Icon  
1/2/2020Derek T ChalmersCEOSell10,000$16.05$160,500.00917,769View SEC Filing Icon  
1/2/2020Jeffrey L. IvesDirectorSell2,500$16.13$40,325.008,500View SEC Filing Icon  
12/4/2019Derek T ChalmersCEOSell10,699$17.05$182,417.95918,468View SEC Filing Icon  
12/4/2019Mani MohindruCFOSell4,755$17.05$81,072.7522,196View SEC Filing Icon  
12/4/2019Scott TerrillionInsiderSell3,980$17.05$67,859.0020,749View SEC Filing Icon  
12/2/2019Derek T ChalmersCEOSell10,000$25.79$257,900.00918,468View SEC Filing Icon  
12/2/2019Jeffrey L. IvesDirectorSell2,500$25.83$64,575.008,500View SEC Filing Icon  
11/1/2019Derek T ChalmersCEOSell5,000$20.79$103,950.00928,468View SEC Filing Icon  
11/1/2019Jeffrey L. IvesDirectorSell2,500$20.68$51,700.008,500View SEC Filing Icon  
10/25/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.91$79,640.0063,886View SEC Filing Icon  
10/18/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.33$77,320.0067,886View SEC Filing Icon  
10/11/2019Frederique Ph.D. MenzaghiSVPSell4,000$18.70$74,800.0071,886View SEC Filing Icon  
10/4/2019Frederique Ph.D. MenzaghiSVPSell4,000$19.19$76,760.0075,886View SEC Filing Icon  
10/1/2019Derek T ChalmersCEOSell10,000$18.28$182,800.00933,468View SEC Filing Icon  
10/1/2019Jeffrey L. IvesDirectorSell2,500$18.21$45,525.008,500View SEC Filing Icon  
9/3/2019Derek T ChalmersCEOSell5,000$23.26$116,300.00943,468View SEC Filing Icon  
9/3/2019Frederique Ph.D. MenzaghiSVPSell20,000$22.92$458,400.0079,886View SEC Filing Icon  
9/3/2019Jeffrey L. IvesDirectorSell2,500$23.31$58,275.008,500View SEC Filing Icon  
8/1/2019Derek T ChalmersCEOSell10,000$23.27$232,700.00948,468View SEC Filing Icon  
8/1/2019Frederique Ph.D. MenzaghiSVPSell20,000$23.24$464,800.0099,886View SEC Filing Icon  
8/1/2019Jeffrey L. IvesDirectorSell2,500$23.24$58,100.008,500View SEC Filing Icon  
7/17/2019Frederique Ph.D. MenzaghiInsiderSell8,996$27.50$247,390.00119,886View SEC Filing Icon  
7/15/2019Mani MohindruCFOSell37,431$25.00$935,775.0051,294View SEC Filing Icon  
7/1/2019Frederique Ph.D. MenzaghiInsiderSell20,000$21.90$438,000.00128,882View SEC Filing Icon  
7/1/2019Jeffrey L. IvesDirectorSell2,500$21.75$54,375.008,500View SEC Filing Icon  
5/29/2019Derek T ChalmersCEOSell5,528$21.42$118,409.76963,996View SEC Filing Icon  
5/29/2019Frederique Ph.D. MenzaghiInsiderSell11,397$21.19$241,502.43160,279View SEC Filing Icon  
5/29/2019Mani MohindruCFOSell2,496$21.39$53,389.4416,359View SEC Filing Icon  
See Full Table
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Cara Therapeutics (NASDAQ:CARA)

56.56% of Cara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CARA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cara Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022State Street Corp1,680,599$20.42M0.0%+12.3%3.136%Search for SEC Filing on Google Icon
5/16/2022Disciplined Growth Investors Inc. MN1,694,350$20.59M0.4%+2.3%3.162%Search for SEC Filing on Google Icon
5/16/2022Vident Investment Advisory LLC107,982$1.31M0.0%+75.9%0.201%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.276,655$3.36M0.0%-5.8%0.516%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG15,781$0.19M0.0%-57.5%0.029%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC159,150$1.93M0.0%-55.9%0.297%Search for SEC Filing on Google Icon
5/13/2022Chescapmanager LLC1,175,392$14.28M1.9%-9.9%2.193%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp551,223$6.70M0.0%-3.2%1.029%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.310,718$3.78M0.0%-16.6%0.580%Search for SEC Filing on Google Icon
5/13/2022Penserra Capital Management LLC189,074$2.30M0.1%-0.8%0.353%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.6,009$73K0.0%+27.7%0.011%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.25,256$0.31M0.0%-5.9%0.047%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,244,377$39.42M0.0%+7.0%6.054%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP792,191$9.63M0.0%+49.1%1.478%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.7,187,124$87.32M0.0%-0.2%13.411%Search for SEC Filing on Google Icon
5/12/2022Commonwealth of Pennsylvania Public School Empls Retrmt SYS36,096$0.44M0.0%+13.1%0.067%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY2,988$36K0.0%-75.4%0.006%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC27,279$0.33M0.0%+49.8%0.051%Search for SEC Filing on Google Icon
5/12/2022Martingale Asset Management L P58,733$0.71M0.0%+14.1%0.110%Search for SEC Filing on Google Icon
5/12/2022Natixis Advisors L.P.37,972$0.46M0.0%+101.2%0.071%Search for SEC Filing on Google Icon
5/12/2022Citigroup Inc.86,370$1.05M0.0%+5.7%0.161%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.115,732$1.41M0.0%-16.1%0.216%Search for SEC Filing on Google Icon
5/12/2022Cambridge Investment Research Advisors Inc.20,132$0.25M0.0%+14.1%0.038%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp439,181$5.34M0.0%+0.7%0.820%Search for SEC Filing on Google Icon
5/11/2022State of Tennessee Treasury Department15,514$0.19M0.0%-44.4%0.029%Search for SEC Filing on Google Icon
5/11/2022Jupiter Asset Management Ltd.193,472$2.35M0.0%+613.3%0.361%Search for SEC Filing on Google Icon
5/11/2022JPMorgan Chase & Co.299,217$3.64M0.0%-10.6%0.558%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP12,564$0.15M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/10/2022ProShare Advisors LLC15,321$0.19M0.0%-17.4%0.029%Search for SEC Filing on Google Icon
5/10/2022Meeder Asset Management Inc.2,302$28K0.0%N/A0.004%Search for SEC Filing on Google Icon
5/10/2022Fox Run Management L.L.C.10,938$0.13M0.1%N/A0.020%Search for SEC Filing on Google Icon
5/9/2022Principal Financial Group Inc.365,982$4.45M0.0%-11.5%0.683%Search for SEC Filing on Google Icon
5/9/2022Swiss National Bank101,100$1.23M0.0%+14.9%0.189%Search for SEC Filing on Google Icon
5/9/2022Qube Research & Technologies Ltd17,018$0.21M0.0%N/A0.032%Search for SEC Filing on Google Icon
5/6/2022IndexIQ Advisors LLC33,798$0.41M0.0%N/A0.063%Search for SEC Filing on Google Icon
5/5/2022Royce & Associates LP111,592$1.36M0.0%+744.0%0.208%Search for SEC Filing on Google Icon
5/5/2022Russell Investments Group Ltd.32,946$0.40M0.0%-14.1%0.061%Search for SEC Filing on Google Icon
5/5/2022Pinnacle Associates Ltd.740,106$8.99M0.2%+93.5%1.381%Search for SEC Filing on Google Icon
5/4/2022Envestnet Asset Management Inc.21,043$0.26M0.0%N/A0.039%Search for SEC Filing on Google Icon
4/29/2022SG Americas Securities LLC75,333$0.92M0.0%-17.5%0.141%Search for SEC Filing on Google Icon
4/28/2022Davy Global Fund Management Ltd126,507$1.54M0.3%-27.7%0.236%Search for SEC Filing on Google Icon
4/27/2022Comerica Bank35,284$0.46M0.0%-3.0%0.066%Search for SEC Filing on Google Icon
4/27/2022New York State Teachers Retirement System47,244$0.57M0.0%+64.4%0.088%Search for SEC Filing on Google Icon
4/26/2022First Citizens Bank & Trust Co.20,208$0.25M0.0%N/A0.038%Search for SEC Filing on Google Icon
4/21/2022Strs Ohio48,800$0.59M0.0%-25.9%0.091%Search for SEC Filing on Google Icon
4/21/2022Zurcher Kantonalbank Zurich Cantonalbank 5,886$72K0.0%-42.3%0.011%Search for SEC Filing on Google Icon
4/21/2022Virginia Retirement Systems ET AL38,400$0.47M0.0%-30.1%0.072%Search for SEC Filing on Google Icon
4/18/2022Rothschild Investment Corp IL51,400$0.63M0.0%+5.1%0.096%Search for SEC Filing on Google Icon
4/14/2022IBM Retirement Fund26,509$0.32M0.0%-34.2%0.050%Search for SEC Filing on Google Icon
4/14/2022State of Alaska Department of Revenue29,130$0.35M0.0%-2.7%0.054%Search for SEC Filing on Google Icon
4/13/2022Baldwin Brothers LLC MA18,327$0.22M0.0%+41.0%0.034%Search for SEC Filing on Google Icon
4/7/2022Woodstock Corp35,522$0.43M0.1%+17.8%0.066%Search for SEC Filing on Google Icon
2/23/2022Barclays PLC80,673$0.98M0.0%+59.1%0.151%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.7,199,126$87.68M0.0%+1.3%13.467%Search for SEC Filing on Google Icon
2/19/2022Vident Investment Advisory LLC61,392$0.75M0.0%+4.1%0.115%Search for SEC Filing on Google Icon
2/19/2022Wells Fargo & Company MN132,793$1.62M0.0%-29.1%0.248%Search for SEC Filing on Google Icon
2/18/2022Comerica Bank36,379$0.43M0.0%-4.9%0.068%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.126,047$1.54M0.0%-58.9%0.236%Search for SEC Filing on Google Icon
2/16/2022Deutsche Bank AG27,277$0.33M0.0%+6.7%0.051%Search for SEC Filing on Google Icon
2/16/2022California State Teachers Retirement System57,834$0.70M0.0%+1.9%0.108%Search for SEC Filing on Google Icon
2/16/2022Parametric Portfolio Associates LLC124,448$1.52M0.0%-34.2%0.233%Search for SEC Filing on Google Icon
2/16/2022State of Tennessee Treasury Department27,883$0.34M0.0%+40.3%0.052%Search for SEC Filing on Google Icon
2/15/2022Penserra Capital Management LLC190,676$2.32M0.0%-1.5%0.357%Search for SEC Filing on Google Icon
2/15/2022Metropolitan Life Insurance Co NY12,146$0.15M0.0%-8.9%0.023%Search for SEC Filing on Google Icon
2/15/2022Stifel Financial Corp59,239$0.72M0.0%-32.5%0.111%Search for SEC Filing on Google Icon
2/15/2022Kingdon Capital Management L.L.C.883,000$10.76M1.2%+23.4%1.652%Search for SEC Filing on Google Icon
2/15/2022Legal & General Group Plc101,138$1.23M0.0%+3.8%0.189%Search for SEC Filing on Google Icon
2/15/2022Cubist Systematic Strategies LLC109,085$1.33M0.0%+481.7%0.204%Search for SEC Filing on Google Icon
2/15/2022Disciplined Growth Investors Inc. MN1,656,861$20.18M0.4%-0.7%3.099%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC109,617$1.34M0.1%+4.7%0.205%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC13,699$0.17M0.1%-7.4%0.026%Search for SEC Filing on Google Icon
2/14/2022Squarepoint Ops LLC14,449$0.18M0.0%+11.1%0.027%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.358,300$4.36M0.0%N/A0.670%Search for SEC Filing on Google Icon
2/14/2022Guggenheim Capital LLC12,324$0.15M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/14/2022Alliancebernstein L.P.45,222$0.55M0.0%-17.7%0.085%Search for SEC Filing on Google Icon
2/14/2022Credit Suisse AG49,625$0.61M0.0%+10.6%0.093%Search for SEC Filing on Google Icon
2/14/2022State Street Corp1,496,500$18.23M0.0%-0.5%2.799%Search for SEC Filing on Google Icon
2/14/2022LPL Financial LLC159,706$1.95M0.0%-4.5%0.299%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.126,047$1.54M0.0%-58.9%0.236%Search for SEC Filing on Google Icon
2/14/2022Nuveen Asset Management LLC328,037$3.86M0.0%-3.1%0.614%Search for SEC Filing on Google Icon
2/14/2022Soleus Capital Management L.P.427,200$5.20M0.5%N/A0.799%Search for SEC Filing on Google Icon
2/14/2022Barclays PLC80,673$0.98M0.0%+59.1%0.151%Search for SEC Filing on Google Icon
2/14/2022Invesco Ltd.293,696$3.58M0.0%+37.2%0.549%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC841,028$10.24M0.0%+0.5%1.573%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC360,950$4.40M0.0%N/A0.675%Search for SEC Filing on Google Icon
2/11/2022Charles Schwab Investment Management Inc.372,481$4.54M0.0%+2.2%0.697%Search for SEC Filing on Google Icon
2/10/2022Rhumbline Advisers129,889$1.58M0.0%-0.8%0.243%Search for SEC Filing on Google Icon
2/10/2022JPMorgan Chase & Co.334,594$4.08M0.0%+190.6%0.626%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC14,187$0.17M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.81,716$1M0.0%+85.3%0.153%Search for SEC Filing on Google Icon
2/10/2022WINTON GROUP Ltd20,316$0.25M0.0%-50.2%0.038%Search for SEC Filing on Google Icon
2/10/2022B. Riley Wealth Management Inc.32,770$0.40M0.0%-4.4%0.061%Search for SEC Filing on Google Icon
2/10/2022Connor Clark & Lunn Investment Management Ltd.137,895$1.68M0.0%-6.6%0.258%Search for SEC Filing on Google Icon
2/9/2022Principal Financial Group Inc.413,618$5.04M0.0%+17.2%0.774%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA36,320$0.44M0.0%-34.6%0.068%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP531,350$6.47M0.0%+50.1%0.994%Search for SEC Filing on Google Icon
2/9/2022Geneos Wealth Management Inc.2,060$25K0.0%-33.4%0.004%Search for SEC Filing on Google Icon
2/8/2022Bank of America Corp DE90,289$1.10M0.0%+26.3%0.169%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC18,555$0.23M0.0%+6.1%0.035%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp569,197$6.93M0.0%-3.8%1.065%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cara Therapeutics logo
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.
Read More on Cara Therapeutics

Today's Range

Now: $8.39
Low: $8.09
High: $8.53

50 Day Range

MA: $11.49
Low: $7.45
High: $13.84

52 Week Range

Now: $8.39
Low: $7.40
High: $18.93

Volume

22,545 shs

Average Volume

594,839 shs

Market Capitalization

$449.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of Cara Therapeutics?

Cara Therapeutics' top insider investors include:
  1. Derek T Chalmers (CEO)
  2. Derek T Chalmers (CEO)
  3. Christopher Posner (CEO)
  4. Frederique PhD Menzaghi (SVP)
  5. Scott Terrillion (Insider)
  6. Joana Goncalves (Insider)
  7. Martin Vogelbaum (Director)
  8. Christopher Posner (Director)
  9. Jeffrey L Ives (Director)
  10. Thomas Charles Reilly (CFO)
Learn More about top insider investors at Cara Therapeutics.

Who are the major institutional investors of Cara Therapeutics?

Cara Therapeutics' top institutional investors include:
  1. BlackRock Inc. — 13.41%
  2. Vanguard Group Inc. — 6.05%
  3. Disciplined Growth Investors Inc. MN — 3.16%
  4. State Street Corp — 3.14%
  5. Chescapmanager LLC — 2.19%
  6. Dimensional Fund Advisors LP — 1.48%
Learn More about top institutional investors of Cara Therapeutics stock.

Which institutional investors are selling Cara Therapeutics stock?

During the last quarter, CARA stock was sold by these institutional investors:
  1. Renaissance Technologies LLC
  2. Chescapmanager LLC
  3. Charles Schwab Investment Management Inc.
  4. Davy Global Fund Management Ltd
  5. Principal Financial Group Inc.
  6. JPMorgan Chase & Co.
  7. Connor Clark & Lunn Investment Management Ltd.
  8. UBS Group AG
During the previous year, company insiders that have sold Cara Therapeutics company stock include:
  1. Derek T Chalmers (CEO)
  2. Derek T Chalmers (CEO)
  3. Christopher Posner (CEO)
  4. Frederique PhD Menzaghi (SVP)
  5. Scott Terrillion (Insider)
  6. Joana Goncalves (Insider)
  7. Martin Vogelbaum (Director)
  8. Christopher Posner (Director)
  9. Jeffrey L Ives (Director)
Learn More investors selling Cara Therapeutics stock.

Which institutional investors are buying Cara Therapeutics stock?

During the previous quarter, CARA stock was purchased by institutional investors including:
  1. Pinnacle Associates Ltd.
  2. Dimensional Fund Advisors LP
  3. Vanguard Group Inc.
  4. State Street Corp
  5. Jupiter Asset Management Ltd.
  6. Royce & Associates LP
  7. Vident Investment Advisory LLC
  8. Disciplined Growth Investors Inc. MN
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!